Qiao Bobo
FDA investigator
Appears on 2 documents from 2023 to 2024, mostly at sites in China. Most often cites control of microbiological contamination (21 CFR 211.113).
- 2
- Documents on file
- 5.5
- Observations per 483
- 2023
- First seen
- 2024
- Most recent
What they cite most
From 11 observations- 21 CFR 211.113Control of microbiological contamination3
- 21 CFR 211.180General requirements1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.52Washing and toilet facilities1
- 21 CFR 211.58Maintenance1
- 21 CFR 211.67Equipment cleaning and maintenance1
Activity by year
2023: 1, 2024: 1
Where
China 1 · Indiana 1
Often inspects with
Is Qiao Bobo coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2024-01-16 | 483 Jiangsu Hengrui Pharmaceuticals Co., LtdJan 16, 2024 · Lianyungang, China | Lianyungang, China | 8 | |
| 2023-10-06 | 483 Eli Lilly and CompanyOct 6, 2023 · Indianapolis, Indiana | Indianapolis, Indiana | 3 |
About this profile
What does Qiao Bobo inspect?
Qiao Bobo appears on 2 documents on file covering 2 sites, mostly in China.
What do they cite most often?
21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.180 and 21 CFR 211.22.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Qiao Bobo is dated Jan 16, 2024.